{
    "slug":  "diabetes-cure-clinical-trials",
    "category":  "Health",
    "title":  "Type 1 Diabetes Cure: Stem Cell Therapy Shows Promise in Trials",
    "introText":  "Stem cell therapy has effectively cured Type 1 diabetes in clinical trials, eliminating the need for insulin injections in treated patients. The breakthrough could free millions from daily diabetes management.",
    "readingTime":  "7 Min Read",
    "author":  {
                   "image":  "/images/authors/author-4.webp",
                   "name":  "David Thompson",
                   "role":  "Financial Correspondent"
               },
    "lastUpdated":  "December 15, 2025",
    "content":  [
                    {
                        "type":  "image",
                        "content":  "Diabetes cure breakthrough",
                        "imageUrl":  "/images/news/healthcare-medical.webp",
                        "imageAlt":  "Healthcare"
                    },
                    {
                        "type":  "heading",
                        "content":  "Trial Results",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "Patients receiving stem cell-derived insulin-producing cells achieved normal blood sugar levels without insulin injections. After one year, 80% remained insulin-independent."
                    },
                    {
                        "type":  "heading",
                        "content":  "How It Works",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "Stem cells are programmed to become insulin-producing beta cells, then implanted in patients. The cells respond to blood sugar levels naturally, eliminating the need for external insulin."
                    },
                    {
                        "type":  "heading",
                        "content":  "Path to Approval",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "Larger trials are underway with FDA fast-track designation. If successful, the treatment could be available by 2027 for the 1.6 million Americans with Type 1 diabetes."
                    }
                ],
    "bookmarked":  false
}
